Work

LXR agonism and Sorafenib treatment as novel combination therapy for hepatocellular carcinoma

Year: 2019

Type: article

Source: The FASEB Journal

DOI: 10.1096/fasebj.2019.33.1_supplement.126.9

Authors: Morgan E. Preziosi, Adam M. Zahm, Klaus H. Kaestner, Kirk J. Wangensteen

Institution: University of Pennsylvania

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3016228957

FWCI: 0.273

Cites:

Cited by: 2

Related to: 10